The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025. In the quarter to June 2026, revenue fell 2.01%, EPS fell 50.4%, free cash flow grew 11.4% and total debt rose 60.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
Follow CLX
The Clorox Company (CLX) EPS (diluted)
The Clorox Company's EPS (diluted) for fiscal 2026 was $4.81, down 26.2% from $6.52 in fiscal 2025. Over the past ten years it has ranged from $1.20 (fiscal 2023) to $7.36 (fiscal 2020); the current reading is higher than 42% of that period. The Clorox Company ranks 4th of 27 Household & Personal Products companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $4.81 | (26.23%) |
| FY2025 | $6.52 | 189.78% |
| FY2024 | $2.25 | 87.50% |
| FY2023 | $1.20 | (67.83%) |
| FY2022 | $3.73 | (33.15%) |
| FY2021 | $5.58 | (24.18%) |
| FY2020 | $7.36 | 16.46% |
| FY2019 | $6.32 | 0.96% |
| FY2018 | $6.26 | 17.45% |
| FY2017 | $5.33 | 8.33% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $1.34 | (12.99%) |
| Mar 2026 | $1.54 | 19.38% |
| Dec 2025 | $1.29 | 98.46% |
| Sep 2025 | $0.65 | (75.75%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| KMB Kimberly-Clark Corporation compare | $5.88 |
| IPAR Interparfums, Inc. compare | $5.23 |
| CLX The Clorox Company | $4.82 |
| CHD Church & Dwight Co., Inc. compare | $3.11 |
| ELF e.l.f. Beauty compare | $1.00 |
| KVUE Kenvue Inc. compare | $0.87 |
| EL The Estee Lauder Companies Inc. compare | $0.49 |
| NWL Newell Brands Inc. compare | −$0.53 |
| COTY Coty compare | −$0.70 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CLX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement